Therapeutic effects of lysophosphatidylcholine in experimental sepsis (original) (raw)

• Hoyert, D.L., Kochanek, K.D. & Murphy, S.L. Deaths: final data for 1997. Natl. Vital Stat. Rep. 47, 1–104 (1999).
  PubMed Google Scholar
• Huber-Lang, M.S. et al. Complement-induced impairment of innate immunity during sepsis. J. Immunol. 169, 3223–3231 (2002).
  Article CAS Google Scholar
• Czermak, B.J. et al. Protective effects of C5a blockade in sepsis. Nat. Med. 5, 788–792 (1999).
  Article CAS Google Scholar
• Docke, W.D. et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med. 3, 678–681 (1997).
  Article CAS Google Scholar
• Wang, S.D., Huang, K.J., Lin, Y.S. & Lei, H.Y. Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152, 5014–5021 (1994).
  CAS PubMed Google Scholar
• Ayala, A. et al. Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood 91, 1362–1372 (1998).
  CAS PubMed Google Scholar
• Hotchkiss, R.S. et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166, 6952–6963 (2001).
  Article CAS Google Scholar
• Hotchkiss, R.S. & Karl, I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138–150 (2003).
  Article CAS Google Scholar
• Bone, R.C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 24, 1125–1128 (1996).
  Article CAS Google Scholar
• Huber-Lang, M.S. et al. Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB J. 15, 568–570 (2001).
  Article CAS Google Scholar
• Hotchkiss, R.S. et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96, 14541–14546 (1999).
  Article CAS Google Scholar
• Kabarowski, J.H., Xu, Y. & Witte, O.N. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol. 64, 161–167 (2002).
  Article CAS Google Scholar
• Quinn, M.T., Parthasarathy, S. & Steinberg, D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA 85, 2805–2809 (1988).
  Article CAS Google Scholar
• Nakano, T., Raines, E.W., Abraham, J.A., Klagsbrun, M. & Ross, R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc. Natl. Acad. Sci. USA 91, 1069–1073 (1994).
  Article CAS Google Scholar
• Liu-Wu, Y., Hurt-Camejo, E. & Wiklund, O. Lysophosphatidylcholine induces the production of IL-1β by human monocytes. Atherosclerosis 137, 351–357 (1998).
  Article CAS Google Scholar
• Coutant, F. et al. Mature dendritic cell generation promoted by lysophosphatidylcholine. J. Immunol. 169, 1688–1695 (2002).
  Article CAS Google Scholar
• Sakai, M. et al. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J. Biol. Chem. 269, 31430–31435 (1994).
  CAS PubMed Google Scholar
• Gomez-Munoz, A., O'Brien, L., Hundal, R. & Steinbrecher, U.P. Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages. J. Lipid Res. 40, 988–993 (1999).
  CAS PubMed Google Scholar
• De Vries, H.E. et al. Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages. FASEB J. 12, 111–118 (1998).
  Article CAS Google Scholar
• Ngwenya, B.Z. & Yamamoto, N. Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages. Cancer Immunol. Immunother. 21, 174–182 (1986).
  Article CAS Google Scholar
• Ramos, M.A. et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 18, 1188–1196 (1998).
  Article CAS Google Scholar
• McMurray, H.F., Parthasarathy, S. & Steinberg, D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92, 1004–1008 (1993).
  Article CAS Google Scholar
• Asaoka, Y., Oka, M., Yoshida, K. & Nishizuka, Y. Lysophosphatidylcholine as a possible second messenger synergistic to diacylglycerol and calcium ion for T-lymphocyte activation. Biochem. Biophys. Res. Commun. 178, 1378–1385 (1991).
  Article CAS Google Scholar
• Nishi, E. et al. Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes. Circ. Res. 80, 638–644 (1997).
  Article CAS Google Scholar
• Nishi, E. et al. Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes. Circ. Res. 83, 508–515 (1998).
  Article CAS Google Scholar
• Asaoka, Y., Oka, M., Yoshida, K., Sasaki, Y. & Nishizuka, Y. Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C. Proc. Natl. Acad. Sci. USA 89, 6447–6451 (1992).
  Article CAS Google Scholar
• Savage, J.E., Theron, A.J. & Anderson, R. Activation of neutrophil membrane-associated oxidative metabolism by ultraviolet radiation. J. Invest. Dermatol. 101, 532–536 (1993).
  Article CAS Google Scholar
• Nishioka, H., Horiuchi, H., Arai, H. & Kita, T. Lysophosphatidylcholine generates superoxide anions through activation of phosphatidylinositol 3-kinase in human neutrophils. FEBS Lett. 441, 63–66 (1998).
  Article CAS Google Scholar
• Silliman, C.C. et al. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J. Leukoc. Biol. 73, 511–524 (2003).
  Article CAS Google Scholar
• Kabarowski, J.H., Zhu, K., Le, L.Q., Witte, O.N. & Xu, Y. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293, 702–705 (2001).
  Article CAS Google Scholar
• Muller Kobold, A.C. et al. Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med. 26, 883–892 (2000).
  Article CAS Google Scholar
• Solomkin, J.S., Jenkins, M.K., Nelson, R.D., Chenoweth, D. & Simmons, R.L. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 90, 319–327 (1981).
  CAS PubMed Google Scholar
• Zhu, K. et al. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276, 41325–41335 (2001).
  Article CAS Google Scholar
• Okajima, F. et al. Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells. Biochem. J. 336, 491–500 (1998).
  Article CAS Google Scholar
• Zantl, N. et al. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect. Immun. 66, 2300–2309 (1998).
  CAS PubMed PubMed Central Google Scholar
• Tzianabos, A.O. et al. IL-2 mediates protection against abscess formation in an experimental model of sepsis. J. Immunol. 163, 893–897 (1999).
  CAS PubMed Google Scholar
• Weighardt, H. et al. Impaired monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis. Ann. Surg. 235, 560–567 (2002).
  Article Google Scholar
• Nakahata, E., Shindoh, Y., Takayama, T. & Shindoh, C. Interleukin-12 prevents diaphragm muscle deterioration in a septic animal model. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 130, 653–663 (2001).
  Article CAS Google Scholar
• Remick, D.G. et al. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality. Crit. Care Med. 29, 473–481 (2001).
  Article CAS Google Scholar
• Matsumoto, T. et al. Contribution of neutrophils to lipopolysaccharide-induced tumor necrosis factor production and mortality in a carrageenan-pretreated mouse model. FEMS Immunol. Med. Microbiol. 17, 171–178 (1997).
  Article CAS Google Scholar
• Drobnik, W. et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J. Lipid Res. 44, 754–761 (2003).
  Article CAS Google Scholar
• Macphee, C.H. Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. Curr. Opin. Pharmacol. 1, 121–125 (2001).
  Article CAS Google Scholar
• Corr, P.B. et al. Pathophysiological concentrations of lysophosphatides and the slow response. Am. J. Physiol. 243, H187–H195 (1982).
  CAS PubMed Google Scholar
• Kishimoto, T., Soda, Y., Matsuyama, Y. & Mizuno, K. An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. Clin. Biochem. 35, 411–416 (2002).
  Article CAS Google Scholar
• Szucs, S., Varga, C., Ember, I. & Kertai, P. The separation of the granulocytes from different rat strains. A comparative study. J. Immunol. Methods 167, 245–251 (1994)
  Article CAS Google Scholar
• Qureshi, M.A. & Dietert, R.R. Bacterial uptake and killing by macrophages. in Methods in Immunotoxicology Vol. 2 (eds. Burleson, G.R., Dean, J.H. & Munson, A.E.) 119–131 (Wiley-Liss, New York, 1995).
  Google Scholar
• Weng, Z. et al. A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M. Proc. Natl. Acad. Sci. USA 95, 12334–12339 (1998).
  Article CAS Google Scholar